GOLDMAN SACHS GROUP INC - ONCTERNAL THERAPEUTICS INC ownership

ONCTERNAL THERAPEUTICS INC's ticker is ONCT and the CUSIP is 68236P107. A total of 76 filers reported holding ONCTERNAL THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ONCTERNAL THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$12,000
-94.3%
13,161
-93.1%
0.00%
Q2 2022$211,000
-9.4%
189,634
+13.0%
0.00%
Q1 2022$233,000
-38.5%
167,849
+0.5%
0.00%
Q4 2021$379,000
-12.7%
167,028
+60.6%
0.00%
Q3 2021$434,000
+313.3%
103,978
+371.4%
0.00%
Q2 2021$105,000
-88.3%
22,055
-79.6%
0.00%
Q1 2021$899,000
+910.1%
108,096
+706.2%
0.00%
Q2 2019$89,00013,4080.00%
Other shareholders
ONCTERNAL THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Quantum Private Wealth, LLC 464,356$464,3560.29%
Beta Wealth Group, Inc. 32,000$32,0000.02%
BRIGHTON JONES LLC 333,875$333,8750.02%
Waypoint Capital Advisors, LLC 38,269$38,2690.01%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 53,554$53,5540.01%
KENNEDY CAPITAL MANAGEMENT LLC 268,242$268,2420.01%
Balboa Wealth Partners 17,500$17,5000.01%
IPG Investment Advisors LLC 23,691$23,6910.01%
AXXCESS WEALTH MANAGEMENT, LLC 70,363$70,3630.01%
IEQ CAPITAL, LLC 144,434$144,4340.00%
View complete list of ONCTERNAL THERAPEUTICS INC shareholders